These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 17571110)

  • 1. [Nevertheless control of documentation of generic drugs?].
    Halse J
    Tidsskr Nor Laegeforen; 2007 Jun; 127(12):1669. PubMed ID: 17571110
    [No Abstract]   [Full Text] [Related]  

  • 2. [The influence of the drug legislation on drug information for the physician and patient].
    Schwabe U
    Internist (Berl); 1980 Jun; 21(6):311-7. PubMed ID: 7005167
    [No Abstract]   [Full Text] [Related]  

  • 3. [Should we accept defective copies?].
    Ostholm I
    Lakartidningen; 1993 Oct; 90(43):3747-8. PubMed ID: 8231521
    [No Abstract]   [Full Text] [Related]  

  • 4. [Documentation and control of drug traffic and consumption].
    Simić N
    Nar Zdrav; 1976; 32(12):66-73. PubMed ID: 1028919
    [No Abstract]   [Full Text] [Related]  

  • 5. UK Medicines Information Bill.
    Medawar C
    Lancet; 1993 May; 341(8854):1219. PubMed ID: 8098111
    [No Abstract]   [Full Text] [Related]  

  • 6. Sluggish generics entry prompts calls for European patent reform.
    Laursen L
    Nat Med; 2009 Nov; 15(11):1239. PubMed ID: 19893542
    [No Abstract]   [Full Text] [Related]  

  • 7. [Generic preparations].
    Ersgaard HV
    Ugeskr Laeger; 2005 Sep; 167(38):3609; author reply 3609-10. PubMed ID: 16219200
    [No Abstract]   [Full Text] [Related]  

  • 8. [Generic preparations are a nuisance].
    Lyftingsmo S
    Tidsskr Nor Laegeforen; 2007 Jun; 127(13):1802-3. PubMed ID: 17599134
    [No Abstract]   [Full Text] [Related]  

  • 9. [Swedish confusion about generic preparations].
    Furuskog P
    Lakartidningen; 2006 Mar 1-7; 103(9):668. PubMed ID: 16583550
    [No Abstract]   [Full Text] [Related]  

  • 10. [Generic preparations and name confusion].
    Nielsen J
    Ugeskr Laeger; 2004 May; 166(23):2273. PubMed ID: 15487531
    [No Abstract]   [Full Text] [Related]  

  • 11. [Confusing drug information].
    Overø J
    Ugeskr Laeger; 2003 Nov; 165(48):4668; author reply 4668-9. PubMed ID: 14677474
    [No Abstract]   [Full Text] [Related]  

  • 12. Controlled substance tracking.
    Beatty Y
    Tenn Med; 2005 Oct; 98(10):467-. PubMed ID: 16294561
    [No Abstract]   [Full Text] [Related]  

  • 13. Direct-to-consumer advertising of prescription drugs: balancing benefits and risks, and a way forward.
    Kravitz RL; Bell RA
    Clin Pharmacol Ther; 2007 Oct; 82(4):360-2. PubMed ID: 17851573
    [No Abstract]   [Full Text] [Related]  

  • 14. The Drug Enforcement Administration's final rule on theft and significant loss reporting: we can see more clearly now.
    Houck LK
    Food Drug Law J; 2006; 61(1):1-11. PubMed ID: 16838455
    [No Abstract]   [Full Text] [Related]  

  • 15. Searching for dollar-saving generics.
    Harv Heart Lett; 2006 Dec; 17(4):6. PubMed ID: 17297672
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug nomenclature: suggestions for change.
    Pollett HF
    CMAJ; 1992 Nov; 147(10):1422. PubMed ID: 1423079
    [No Abstract]   [Full Text] [Related]  

  • 17. [Wrong solution of a serious problem].
    Verland K
    Ugeskr Laeger; 2004 May; 166(20):1920. PubMed ID: 15202388
    [No Abstract]   [Full Text] [Related]  

  • 18. Sangstat recalls SangCya. New-found study shows biocompatibility problems with Neoral.
    Neumann ME
    Nephrol News Issues; 2000 Aug; 14(9):S4. PubMed ID: 11933432
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug nomenclature suggestions for change.
    Rutter P
    CMAJ; 1992 Nov; 147(10):1422. PubMed ID: 1423078
    [No Abstract]   [Full Text] [Related]  

  • 20. In the name of safety.
    Parish C
    Nurs Stand; 2002 Oct 30-Nov 5; 17(7):12. PubMed ID: 12452078
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.